Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
15M Doses Of JNJ COVID-19 Vaccine Batch Ruined After Ingredient Issues At Emergent Biosolutions' US Plant: NYT
05:51am, Thursday, 01'st Apr 2021
One batch of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccines failed quality standards and are not fit for use, reported the New York Times on late Wednesday. What Happened: The company had foun
Emergent Biosolutions Stock Takes A Hit From Vaccine Mix-Up At Baltimore Plant
05:00am, Thursday, 01'st Apr 2021
Johnson & Johnson confirmed yesterday that a batch of its Covid-19 vaccine was contaminated by ingredients from AstraZeneca's vaccine at Emergent Biosolutions' manufacturing plant in Baltimore due to
5 Health Care Stocks Boosting Earnings
11:42am, Wednesday, 31'st Mar 2021
The following health care companies have grown their earnings per share over a five-year period. According to the GuruFocus discounted cash flow calculator as of March 31, all of them also trade with
Coronavirus vaccine: The world is going to need billions of doses...: Emergent Biosolutions CEO
02:05pm, Thursday, 04'th Mar 2021
Emergent Biosolutions CEO Robert Kramer discusses coronavirus vaccine production and distribution.
Emergent BioSolutions says it can make 1 billion Covid vaccine doses annually
07:24pm, Wednesday, 03'rd Mar 2021
Emergent CEO Bob Kramer told CNBC that the company has infrastructure in place to produce Johnson & Johnson and AstraZeneca vaccines around the clock.
Emergent Biosolutions CEO talks production of Johnson & Johnson vaccine
07:20pm, Wednesday, 03'rd Mar 2021
Emergent Biosolutions last year signed a multi-year agreement with the U.S. and Johnson & Johnson to handle domestic manufacturing of a Covid-19 vaccine. CEO Bob Kramer gives an update on the effort.
Emergent BioSolutions to Participate in Investor Conferences
06:30am, Monday, 01'st Mar 2021
GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company's senior management team will participate in the following inve
What Should You Do With Emergent Biosolutions Stock After A 19% Drop In 5 Days?
10:40am, Friday, 26'th Feb 2021
The stock price of Emergent Biosolutions, a biopharmaceutical company focused on vaccines and antibody therapeutics for infectious diseases, and opioid overdoses, has seen a 17% drop over the last ten
Abercrombie, Mattel, Western Digital and More Wednesday Afternoon Analyst Calls
12:27pm, Wednesday, 24'th Feb 2021
With the trading day more than halfway over, the broad markets have pushed higher, seemingly recovering from Tuesday.
Why Emergent BioSolutions Stock Is Sliding Today
11:27am, Friday, 19'th Feb 2021
An analyst downgraded the stock.
Emergent (EBS) Beats on Q4 Earnings, Misses on Revenues
11:20am, Friday, 19'th Feb 2021
Emergent's (EBS) earnings in the fourth quarter of 2020 beat estimates while revenues miss the same. Sales of contract development and manufacturing services rise.
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2020 Results - Earnings Call Transcript
11:32pm, Thursday, 18'th Feb 2021
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2020 Results - Earnings Call Transcript
Emergent BioSolutions: Q4 Earnings Insights
04:45pm, Thursday, 18'th Feb 2021
Shares of Emergent BioSolutions (NYSE:EBS) increased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 133.76% over the past year to $3.67, whic
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020
04:05pm, Thursday, 18'th Feb 2021
GAITHERSBURG, Md., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2020. The Company also reaffirm
Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18, 2021
06:30am, Thursday, 04'th Feb 2021
GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 18, 2021 at 5:00 pm eastern time to discuss the financial
